TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-31 07:46 am Unchanged | 2024-07-31 | 13G | Xilio Therapeutics, Inc. XLO | TAKEDA PHARMACEUTICAL CO LTD | 1,475,121 4.000% | 0 (Unchanged) | Filing |
| 2022-01-14 06:07 am Purchase | 2021-12-31 | 13G | Xilio Therapeutics, Inc. XLO | TAKEDA PHARMACEUTICAL CO LTD | 1,475,121 5.370% | 1,475,121 (New Position) | Filing |